Occupational exposure limits in the context of solvent mixtures, consumption of ethanol, and target tissue dose

Toxicology and Industrial Health

Volumn 20, Issue 10, 2004, Pages 165-175

  Dennison, James E ^a   Bigelow, Philip L ^b   Andersen, Melvin E ^c  

^a Department of Ecosystem Science and Sustainability   (United States)

^b INSTITUTE FOR WORK AND HEALTH   (Canada)

^c CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

CYP2E1; ethanol; induction; inhibition; mixtures; OELs; PBPK; TLVs

Indexed keywords

ALCOHOL; BENZENE; CYTOCHROME P450 2E1; SOLVENT; TOLUENE;

ALCOHOL CONSUMPTION; CHEMICAL COMPOSITION; CHEMICAL INTERACTION; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG DISPOSITION; DRUG MIXTURE; ENZYME METABOLISM; EVALUATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OCCUPATIONAL EXPOSURE; PREDICTION; REVIEW; TARGET ORGAN;

ALCOHOL DRINKING; COMPLEX MIXTURES; CYTOCHROME P-450 CYP2E1; DRUG INTERACTIONS; ETHANOL; GUIDELINES; HUMANS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; OCCUPATIONAL EXPOSURE; ORGANIC CHEMICALS; SOLVENTS;

EID: 18744409110     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1191/0748233704th203oa     Document Type: Article

References (41)

1. ACGIH, 2004a: 2004 TLVs and BEIs: Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati: American Conference of Governmental Industrial Hygienists (ACGIH).
2. ACGIH, 2004b: Documentation of the Threshold Limit Values and Biological Exposure Indices. Cincinnati: American Conference of Governmental Industrial Hygienists (ACGIH).
3. Andersen, M. E., Jones, R. A. and Jenkins L. J. 1978: The acute toxicity of single, oral doses of 1,1-dichloroethylene in the fasted, male rat: effect of induction and inhibition of microsomal enzyme activities on mortality. Toxicology and Applied Pharmacology 46, 227-234.
4. Andersen, M. E., Gargas, M. L., Clewell, H. J. D. and Severyn, K. M. 1987: Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicology and Applied Pharmacology 89, 149-157.
5. Badger, T. M., Huang, J., Ronis, M. and Lumpkin, C. K. 1993: Induction of cytochrome P450 2E1 during chronic ethanol exposure occurs via transcription of the CYP 2E1 gene when blood alcohol concentrations are high. Biochemical and Biophysical Research Communications 190, 780-785.
6. Barton, H. A., Creech, J. R., Godin, C. S. et al. 1995: Chloroethylene mixtures: pharmacokinetic modeling and in vitro metabolism of vinyl chloride, trichloroethylene, and trans- 1,2-dichloroethylene in rat. Toxicology and Applied Pharmacology 130, 237-247.
7. Corti, M. and Snyder, C. A. 1998: Gender- and age-specific cytotoxic susceptibility to benzene metabolites in vitro. Toxicological Sciences 41, 42-48.
8. ECETOC, 1997: Occupational exposure limits for hydrocarbon solvents. Special Report No. 13, August 1997. Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC).
9. Emery, M. G., Jubert, C., Thummel, K. E. and Kharasch, E. D. 1999: Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans. Journal of Pharmacology and Experimental Therapeutics 291, 213-219.
10. George, J., Byth, K. and Farrell, G. C. 1995a: Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochemical Pharmacology 50, 727-730.
11. George, J., Murray, M., Byth, K. and Farrell, G. C. 1995b: Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 21, 120-128.
12. Guengerich, F. P., Kim, D. H. and Iwasaki, M. 1991: Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology 4, 168-179.
13. Gut, I., Terelius, Y., Frantik, E., Linhart, I., Soucek, P., Filipcova, B. and Kluckova, H. 1993: Exposure to various benzene derivatives differently induces cytochromes P450 2B1 and P450 2E1 in rat liver. Archives of Toxicology 67, 237-243.
14. Ingelman-Sundberg, M. and Jornvall, H. 1984: Induction of the ethanol-inducible form of rabbit liver microsomal cytochrome P-450 by inhibitors of alcohol dehydrogenase. Biochemical and Biophysical Research Communications 124, 375-382.
15. Jang, J. Y. and Droz, P. O. 1997: Ethnic differences in biological monitoring of several organic solvents. II. A simulation study with a physiologically based pharmacokinetic model. International Archives of Occupational and En-vironmental Health 70, 41-50.
16. Jin, L. and Baillie, T. A. 1997: Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats. Chemical Research in Toxicology 10, 318-327.
17. Kaneko, T., Wang, P. Y. and Sato, A. 1993: Enzyme induction by ethanol consumption affects the pharmacokinetics of inhaled m-xylene only at high levels of exposure. Archives of Toxicology 67, 473-477.
18. Kenyon, E. M., Seaton, M. J., Himmelstein, M. W., Asgharian, B. and Medinsky, M. A. 1998: Influence of gender and acetone pretreatment on benzene metabolism in mice exposed by nose-only inhalation. Journal of Toxicology and Environmental Health 55, 421-443.
19. Kim, S. G., Williams, D. E., Schuetz, E. G., Guzelian, P. S. and Novak, R. F. 1988: Pyridine induction of cytochrome P- 450 in the rat: role of P-450j (alcohol-inducible form) in pyridine N-oxidation. Journal of Pharmacology and Experimental Therapeutics 246, 1175-1182.
20. Klaassen, C. D., editor, Casarett and Doull's Toxicology: The Basic Science of Poisons, 5th ed. New York: McGraw Hill, 1995.
21. Kolp, P. W., Williams, P. L. and Burtan, R. C. 1995: Assessment of the accuracy of material safety data sheets. American Industrial Hygiene Association Journal 56, 178-183.
22. Krishnan, K., Clewell, H. J. and Andersen, M. E. 1994: Physiologically based pharmacokinetic analyses of simple mixtures. Environmental Health Perspectives 102 (Suppl 9), 151-155.
23. Leung, H. W. 1992: Use of physiologically based pharmacokinetic models to establish biological exposure indexes. American Industrial Hygiene Association Journal 53, 369-374.
24. OSHA, 1997. Methylene Chloride VI. Quantitative Risk Assessment. 62 FR 1494, January 10, 1997. Washington, DC: US Occupational Safety and Health Administration (OSHA).
25. OSHA, 2004. Air Contaminants: 29 CFR 1910.1000 (d): Occupational Safety and Health Administration.
26. Perrot, N., Nalpas, B., Yang, C. S. and Beaune, P. H. 1989: Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake. European Journal of Clinical Investigations 19, 549-555.
27. Preston, R. J. 1996: Interindividual variations in susceptibility and sensitivity: linking risk assessment and risk management. Toxicology 111, 331-341.
28. Purcell, K. J., Cason, G. H., Gargas, M. L., Andersen, M. E. and Travis, C. C. 1990: In vivo metabolic interactions of benzene and toluene. Toxicology Letters 52, 141-152.
29. Ramsey, J. C. and Andersen, M. E. 1984: A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicology and Applied Pharmacology 73, 159-175.
30. Raucy, J. L. 1995: Risk assessment: toxicity from chemical exposure resulting from enhanced expression of CYP2E1. Toxicology 105, 217-224.
31. Raucy, J. L., Lasker, J. M., Kraner, J. C., Salazar, D. E., Lieber, C. S. and Corcoran, G. B. 1991: Induction of cytochrome P450IIE1 in the obese overfed rat. Molecular Pharmacology 39, 275-280.
32. Roberts, E. S., Alworth, W. L. and Hollenberg, P. F. 1998: Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne. Archives of Biochemistry and Biophysics 354, 295-302.
33. Sato, A., Endoh, K., Kaneko, T. and Johanson, G. 1991: Effects of consumption of ethanol on the biological monitoring of exposure to organic solvent vapours: a simulation study with trichloroethylene. British Journal of Industrial Medicine 48, 548-556.
34. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. and Guengerich, F. P. 1994: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics 270, 414-423.
35. Spear, R. C. and Bois, F. Y. 1994: Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results. Environmental Health Perspectives 102 (Suppl 11), 61-66.
36. Stephens, E. A., Taylor, J. A., Kaplan, N., Yang, C. H., Hsieh, L. L., Lucier, G. W. and Bell, D. A. 1994: Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics 4, 185-192.
37. Tardif, R., Lapare, S., Charest-Tardif, G., Brodeur, J. and Krishnan, K. 1995: Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans. Risk Analysis 15, 335-342.
38. Thomas, R. S., Lytle, W. E., Keefe, T. J., Constan, A. A. and Yang, R. S. 1996: Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): a computational method. Fundamental and Applied Toxicology 31, 19-28.
39. USEPA, 1996: Proposed guidelines for carcinogen risk assessment. EPA/600/P-92/003C, April, 1996. Washington, DC: US Environmental Protection Agency.
40. USEPA, 1997: Guiding Principles for Monte Carlo Analysis. EPA/630/R-97/001, March, 1997. Washington, DC: USEPA.
41. Yang, R. S., el-Masri, H. A., Thomas, R. S. et al. 1995: The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling for exploring risk assessment approaches of chemical mixtures. Toxicology Letters 79: 193-200.